VICTORIA, Sept. 13 /CNW/ - Aspreva Pharmaceuticals Corporation (NASDAQ: ASPV; TSX: ASV) today announced that Noel Hall, President and Co-Founder, will be presenting at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference in London, England.
